LeMaitre Vascular's Key Investor Conferences in March
BURLINGTON, Mass. — LeMaitre Vascular, Inc. (Nasdaq: LMAT) has announced an exciting opportunity for investors as the company prepares to take part in several important investor conferences this month. This will enable LeMaitre to showcase its innovative vascular solutions aimed at improving healthcare outcomes.
Engagements with Investors
The first major conference on LeMaitre's calendar is the 37th Annual ROTH Conference, taking place on March 17. This prestigious conference, held at the Laguna Cliffs Marriott in Dana Point, California, will feature a presentation by management at 4:00 PM PDT. This event is a significant platform for LeMaitre to connect with investors and discuss the company’s strategies and performance.
KeyBanc Healthcare Forum Participation
Following the ROTH Conference, LeMaitre will participate in the KeyBanc Healthcare Forum on March 19. This virtual event presents another excellent opportunity for management to engage with investors, where they will share insights into the company's advancements and future plans at 1:30 PM EDT.
Oppenheimer Healthcare MedTech Conference
Additionally, on March 20, LeMaitre will be part of the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, also a virtual engagement. Management will present at 10:00 AM EDT, and this conference will further round out LeMaitre's efforts to inform and connect with potential and existing investors.
Innovative Solutions in Vascular Health
As a key player in the vascular sector, LeMaitre specializes in providing advanced devices, implants, and services tailored for the treatment of peripheral vascular disease. This condition is alarmingly prevalent, impacting over 200 million individuals globally. By developing both disposable and implantable vascular devices, LeMaitre addresses the essential needs of vascular surgeons, ultimately aiming to enhance patient outcomes.
Commitment to Healthcare Excellence
LeMaitre's commitment extends beyond merely participating in conferences; it embodies a dedication to pushing the boundaries of vascular health technologies. With a comprehensive understanding of the challenges faced by healthcare providers, LeMaitre is on a mission to deliver innovative solutions that meet the evolving needs of the industry.
Frequently Asked Questions
What are the main investor conferences LeMaitre Vascular is attending?
LeMaitre Vascular is attending the 37th Annual ROTH Conference, KeyBanc Healthcare Forum, and the Oppenheimer 35th Annual Healthcare MedTech & Services Conference.
When will LeMaitre's presentations take place?
The presentations are scheduled for March 17, March 19, and March 20 at various times throughout the day.
What is the focus of LeMaitre Vascular's business?
LeMaitre Vascular focuses on developing devices and implants for the treatment of peripheral vascular disease.
How does LeMaitre support healthcare providers?
LeMaitre supports healthcare providers with innovative vascular solutions that enhance treatment capabilities for patients with vascular conditions.
Where can more information about LeMaitre be found?
More information can be accessed through LeMaitre Vascular's official website.